<table border="1">
  <thead>
    <tr>
      <th>ðŸ“… Year</th>
      <th>ðŸ’° Revenue</th>
      <th>ðŸ’¸ Free Cash Flow</th>
      <th>ðŸ“Š Free Cash Flow Margin</th>
      <th>ðŸ”¬ R&D Expenses</th>
      <th>ðŸ”¬ R&D as % of Revenue</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><strong>2023</strong></td>
      <td><strong>$574.8B</strong></td>
      <td><strong>$32.2B</strong></td>
      <td><strong>5.60%</strong></td>
      <td><strong>$85.6B</strong></td>
      <td><strong>14.89%</strong></td>
    </tr>
    <tr>
      <td><strong>2022</strong></td>
      <td><strong>$514.0B</strong></td>
      <td><strong>$-16.9B</strong></td>
      <td><strong>-3.29%</strong></td>
      <td><strong>$73.2B</strong></td>
      <td><strong>14.24%</strong></td>
    </tr>
    <tr>
      <td><strong>2021</strong></td>
      <td><strong>$469.8B</strong></td>
      <td><strong>$-14.7B</strong></td>
      <td><strong>-3.13%</strong></td>
      <td><strong>$56.1B</strong></td>
      <td><strong>11.94%</strong></td>
    </tr>
    <tr>
      <td><strong>2020</strong></td>
      <td><strong>$386.1B</strong></td>
      <td><strong>$25.9B</strong></td>
      <td><strong>6.71%</strong></td>
      <td><strong>$42.7B</strong></td>
      <td><strong>11.06%</strong></td>
    </tr>
    <tr>
      <td><strong>2019</strong></td>
      <td><strong>$280.5B</strong></td>
      <td><strong>$21.7B</strong></td>
      <td><strong>7.74%</strong></td>
      <td><strong>$35.9B</strong></td>
      <td><strong>12.80%</strong></td>
    </tr>
    <tr>
      <td><strong>2018</strong></td>
      <td><strong>$232.9B</strong></td>
      <td><strong>$17.3B</strong></td>
      <td><strong>7.43%</strong></td>
      <td><strong>$28.8B</strong></td>
      <td><strong>12.36%</strong></td>
    </tr>
  </tbody>
</table>

<p>The <strong>Compound Annual Growth Rate (CAGR)</strong> of <strong>Revenue</strong> from 2018 to 2023 is approximately <strong>19.20%</strong>. The <strong>Free Cash Flow Margin</strong> has worsened from 2018 to 2023, showing a negative trend in 2021 and 2022 but rebounding in 2023. The <strong>R&D spending as a percentage of revenue</strong> has increased year-over-year since 2020, indicating a growing investment in research and development relative to revenue.</p>